로딩 중…
지수 로딩 중…
i-SENS, Inc.
099190· KOSDAQ· Health Care· Health Care Equipment & Services
₩16,360+1.24%
2026-06-19
Price Chart
i-SENS, Inc.+0.12%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 470.47B KRW |
| Revenue | 314.31B KRW |
| Net Income | -11.67B KRW |
| Total Assets | 591.04B KRW |
| Net Assets | 356.49B KRW |
| Employees | 904 |
| Value | |
| P/B | 1.32x |
| P/S | 1.50x |
| EV/EBITDA | 105.56x |
| FCF Yield | -1.61% |
| Profitability | |
| ROE | -3.27% |
| ROA | -1.97% |
| Op. Margin | 1.78% |
| Revenue Growth | -1.49% |
| Earnings Growth | -38.48% |
| Financial Health | |
| Debt Ratio | 65.80% |
| Total Debt | 167.74B KRW |
| FCF | -7.60B KRW |
| Cash | 48.25B KRW |
| Current Ratio | 1.70x |
| Net Debt/EBITDA | 21.38x |
| Dividend | |
| Div. Yield | 0.62% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | 0.12% |
| 1M Return | -7.15% |
| From 52W High | -40.72% |
| 1Y MDD | -42.37% |
| Trading | |
| Volume | 193,568 shares |
| Foreign Own. | 25.68% |
| Per Share | |
| EPS | -209 KRW |
| BPS | 11,625 KRW |
Company Info
Established in 2000, this company develops, manufactures, and sells medical sensors and measuring instruments using electrochemical and biosensor technologies. Its blood glucose meter segment, including self-monitoring and continuous glucose monitoring systems, accounts for over 80% of sales, while the point-of-care testing (POCT) segment for critical care analysis equipment contributes 10%. The company holds world-leading technology for blood sample volume (0.5㎕) and measurement speed (5 seconds), expanding global market share with the domestic launch of CareSens Air, the first continuous glucose monitoring system in Korea. i-SENS is headquartered in Seocho-gu, Seoul.